Nektar Therapeutics (NASDAQ: NKTR) has been on a rollercoaster ride. Between March 2017 and March 2018, the stock rose more than 600%. Since then however, it has fallen -65%. The commercial-stage biotech fell -36.5% in October alone as investors lost faith in the stock. So what happened? Earlier this year, Bristol-Myers Squibb (NYSE: BMY) shelled […]
Read MoreThis morning as the market opened, I was watching CNBC and scrolling through market headlines on my phone as I usually do, trying to get a sense for what the day’s drivers might be. A couple of headlines caught my attention because they were effective at using attention-grabbing words; if you’re a little attention deficit-oriented […]
Read MoreThe stock market has seen a lot of turmoil and turbulence since the beginning of October, with all three major indices touching, or coming very near to the 10% level that most technicians consider correction territory. What you may or may not be aware of, however is that at nearly the same time the stock […]
Read MoreApple Inc. (AAPL) is one of the biggest companies in the world; in August of this year, with the stock pushing nicely above $200 per share, they were the first company in the modern era to officially cross the $1 trillion dollar threshold. And over the last ten years, it is without a doubt one […]
Read MoreIf you were watching the market sell off again yesterday, you probably started to wonder as I did if the market was really starting to follow through on the bearish sentiment that drove it back into correction territory for the Dow and the NASDAQ. The S&P plunged nearly 2% amid worries that the entire tech […]
Read MoreThroughout most of this year, semiconductors have been perhaps the most distressed sector of the market. Before bottoming at the end of the October, the sector had dropped a little over 21% from its high point in mid-March as measured by the iShares Semiconductor ETF (SOXX), and is still down nearly 15% as of Thursday’s […]
Read MoreOctober was a rough month for the stock market, proven by the decline of the NASDAQ and Dow Jones Industrial Average into clear correction territory, while the S&P 500 halted its own slide just shy of that mark. It was enough to put a lot of investors and analysts on edge and start to wonder […]
Read MoreYesterday marked another volatile day in the stock market, as the major indices posted big losses during the trading session – the Dow, for example bottomed out about 500 points below Monday’s close – but managed to claw back late to finish about .5% lower for the day. The market was chewing on a new […]
Read MoreYou’ve heard the phrase, “be greedy when others are fearful.” Judging by the plunge in stocks this month, I think it’s safe to say investors are spooked. Market sell-offs like we’ve seen in the last few weeks tend to create opportunities, and there are two good opportunities in the healthcare sector that investors can now […]
Read MoreThe stock market has been looking dicey for the past month, and lots of big names are sounding the alarm bells that this bull market is on its last legs. While it may be more fun to look at growth stocks even at frothy valuations, the stocks that have been doing alright over the past […]
Read MoreFor investors focused on cash flow or retirees who need their assets to generate income, dividend stocks are at the top of heap. Often though, these income stocks don’t offer much excitement or growth. But you shouldn’t have to sacrifice growth when investing in dividend yielders, and each of the following three stocks offer both […]
Read MoreThe midterms are over, and the big winner is… Marijuana. This week, three states voted to legalize marijuana in some capacity. Michigan became the 10th U.S. state to legalize recreational pot, and is projected to become the fifth-largest marijuana market in the country with sales of roughly $1.4 billion by 2022. Overwhelmingly conservative Utah also […]
Read MoreAfter months of campaign ads and political saber-rattling, the midterms are finally over. Now it’s time to focus on something else. Something like what stocks to buy at a discount after a difficult October. And now is likely a good time to buy. The third year of any presidency or the year following midterm elections […]
Read MoreTech stocks have been one of the strongest drivers of market performance for the past several years. Lately though, tech stocks have stumbled with some of the biggest names giving mixed guidance and weak earnings. And, unsurprisingly, investors have ditched these big name stocks and it has resulted in huge losses. Amazon (NASDAQ: AMZN) lost […]
Read MoreGeneral Motors (NYSE: GM) has had a good week. After reporting a 25% increase in third quarter operating profit on Tuesday, the stock jumped nearly 10% in early trading Wednesday and is currently up nearly 14% for the week. The $2.5 billion reported profit was thanks to higher vehicle prices and increased SUV and truck […]
Read More